BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 21683090)

  • 1. Regulation of the equilibrium between G-quadruplex and duplex DNA in promoter of human c-myc oncogene by a pyrene derivative.
    Zhang Z; He X; Yuan G
    Int J Biol Macromol; 2011 Dec; 49(5):1173-6. PubMed ID: 21683090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 12-N-Methylated 5,6-dihydrobenzo[c]acridine derivatives: a new class of highly selective ligands for c-myc G-quadruplex DNA.
    Liao SR; Zhou CX; Wu WB; Ou TM; Tan JH; Li D; Gu LQ; Huang ZS
    Eur J Med Chem; 2012 Jul; 53():52-63. PubMed ID: 22513122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of the biologically relevant G-quadruplex in the c-MYC promoter.
    Yang D; Hurley LH
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(8):951-68. PubMed ID: 16901825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing c-MYC expression by targeting quadruplex in P1 promoter using locked nucleic acid trap.
    Kumar N; Patowary A; Sivasubbu S; Petersen M; Maiti S
    Biochemistry; 2008 Dec; 47(50):13179-88. PubMed ID: 19053274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 9-N-Substituted berberine derivatives: stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc.
    Ma Y; Ou TM; Hou JQ; Lu YJ; Tan JH; Gu LQ; Huang ZS
    Bioorg Med Chem; 2008 Aug; 16(16):7582-91. PubMed ID: 18674916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based optimization of FDA-approved drug methylene blue as a c-myc G-quadruplex DNA stabilizer.
    Chan DS; Yang H; Kwan MH; Cheng Z; Lee P; Bai LP; Jiang ZH; Wong CY; Fong WF; Leung CH; Ma DL
    Biochimie; 2011 Jun; 93(6):1055-64. PubMed ID: 21377506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stabilization of G-quadruplex DNA with platinum(II) Schiff base complexes: luminescent probe and down-regulation of c-myc oncogene expression.
    Wu P; Ma DL; Leung CH; Yan SC; Zhu N; Abagyan R; Che CM
    Chemistry; 2009 Dec; 15(47):13008-21. PubMed ID: 19876976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based design of platinum(II) complexes as c-myc oncogene down-regulators and luminescent probes for G-quadruplex DNA.
    Wang P; Leung CH; Ma DL; Yan SC; Che CM
    Chemistry; 2010 Jun; 16(23):6900-11. PubMed ID: 20437426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dihydroindolizino indole derivative selectively stabilizes G-quadruplex DNA and down-regulates c-MYC expression in human cancer cells.
    Nagesh N; Raju G; Srinivas R; Ramesh P; Reddy MD; Reddy ChR
    Biochim Biophys Acta; 2015 Jan; 1850(1):129-40. PubMed ID: 25452213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The flanking sequence contributes to the immobilisation of spermine at the G-quadruplex in the NHE (nuclease hypersensitivity element) III1 of the c-Myc promoter.
    Keniry MA; Owen EA
    FEBS Lett; 2014 May; 588(10):1949-54. PubMed ID: 24735723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The c-MYC NHE III(1): function and regulation.
    González V; Hurley LH
    Annu Rev Pharmacol Toxicol; 2010; 50():111-29. PubMed ID: 19922264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel molecular mechanism for actinomycin D activity as an oncogenic promoter G-quadruplex binder.
    Kang HJ; Park HJ
    Biochemistry; 2009 Aug; 48(31):7392-8. PubMed ID: 19496619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectroscopy probing of the formation, recognition, and conversion of a G-quadruplex in the promoter region of the bcl-2 oncogene.
    Li H; Liu Y; Lin S; Yuan G
    Chemistry; 2009; 15(10):2445-52. PubMed ID: 19156807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disubstituted 1,8-dipyrazolcarbazole derivatives as a new type of c-myc G-quadruplex binding ligands.
    Chen WJ; Zhou CX; Yao PF; Wang XX; Tan JH; Li D; Ou TM; Gu LQ; Huang ZS
    Bioorg Med Chem; 2012 May; 20(9):2829-36. PubMed ID: 22484007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cell proliferation by quindoline derivative (SYUIQ-05) through its preferential interaction with c-myc promoter G-quadruplex.
    Ou TM; Lin J; Lu YJ; Hou JQ; Tan JH; Chen SH; Li Z; Li YP; Li D; Gu LQ; Huang ZS
    J Med Chem; 2011 Aug; 54(16):5671-9. PubMed ID: 21774525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quinazoline derivative QPB-15e stabilizes the c-myc promoter G-quadruplex and inhibits tumor growth in vivo.
    Li Z; Liu C; Huang C; Meng X; Zhang L; He J; Li J
    Oncotarget; 2016 Jun; 7(23):34266-76. PubMed ID: 27144522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico identification of novel ligands for G-quadruplex in the c-MYC promoter.
    Kang HJ; Park HJ
    J Comput Aided Mol Des; 2015 Apr; 29(4):339-48. PubMed ID: 25527072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of triethylene tetraamine on the G-quadruplex structure in the human c-myc promoter.
    Yin F; Liu J; Deng X; Wang J
    J Biochem; 2007 May; 141(5):669-74. PubMed ID: 17339229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinolino-benzo-[5, 6]-dihydroisoquindolium compounds derived from berberine: a new class of highly selective ligands for G-quadruplex DNA in c-myc oncogene.
    Ma Y; Ou TM; Tan JH; Hou JQ; Huang SL; Gu LQ; Huang ZS
    Eur J Med Chem; 2011 May; 46(5):1906-13. PubMed ID: 21392861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quadruplex-duplex competition in the nuclease hypersensitive element of human c-myc promoter: C to T mutation in C-rich strand enhances duplex association.
    Halder K; Mathur V; Chugh D; Verma A; Chowdhury S
    Biochem Biophys Res Commun; 2005 Feb; 327(1):49-56. PubMed ID: 15629428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.